Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP). uri icon

authors

  • Kilday, John-Paul
  • Lowe, James
  • Ellison, David W
  • Gilbertson, Richard J
  • Coyle, Beth
  • Grill, Jacques
  • Grundy, Richard G
  • Mitra, Biswaroop
  • Domerg, Caroline
  • Ward, Jennifer
  • Andreiuolo, Felipe
  • Osteso-Ibanez, Teresa
  • Mauguen, Audrey
  • Varlet, Pascale
  • Le Deley, Marie-Cecile

publication date

  • January 1, 2012